These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26997642)

  • 1. Classification of patients with non-alcoholic fatty liver disease using rapid immunoassay of serum type IV collagen compared with liver histology and other fibrosis markers.
    Mizuno M; Shima T; Oya H; Mitsumoto Y; Mizuno C; Isoda S; Kuramoto M; Taniguchi M; Noda M; Sakai K; Koyama N; Okanoue T
    Hepatol Res; 2017 Feb; 47(2):216-225. PubMed ID: 26997642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new detection system for serum fragmented cytokeratin 18 as a biomarker reflecting histologic activities of human nonalcoholic steatohepatitis.
    Eguchi A; Iwasa M; Yamada M; Tamai Y; Shigefuku R; Hasegawa H; Hirokawa Y; Hayashi A; Okuno K; Matsushita Y; Nakatsuka T; Enooku K; Sakaguchi K; Kobayashi Y; Yamaguchi T; Watanabe M; Takei Y; Nakagawa H
    Hepatol Commun; 2022 Aug; 6(8):1987-1999. PubMed ID: 35485207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wisteria floribunda agglutinin-positive Mac-2-binding protein and type 4 collagen 7S: useful markers for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease.
    Ogawa Y; Honda Y; Kessoku T; Tomeno W; Imajo K; Yoneda M; Kawanaka M; Kirikoshi H; Ono M; Taguri M; Saito S; Yamanaka T; Wada K; Nakajima A
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1795-1803. PubMed ID: 29633352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of Type IV Collagen Turnover Reflect Disease Activity in Patients with Early-Stage Non-Alcoholic Fatty Liver (NAFL).
    Lønsmann I; Grove JI; Haider A; Kaye P; Karsdal MA; Leeming DJ; Aithal GP
    Biology (Basel); 2023 Aug; 12(8):. PubMed ID: 37626973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis.
    Alkhouri N; Johnson C; Adams L; Kitajima S; Tsuruno C; Colpitts TL; Hatcho K; Lawitz E; Lopez R; Feldstein AE
    PLoS One; 2018; 13(8):e0202226. PubMed ID: 30161179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis.
    Du SX; Lu LL; Geng N; Victor DW; Chen LZ; Wang C; Yue HY; Xin YN; Xuan SY; Jin WW
    Lipids Health Dis; 2017 Dec; 16(1):228. PubMed ID: 29197393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in the Management of NAFLD/NASH].
    Aizawa Y
    Rinsho Byori; 2016 Jul; 64(7):797-805. PubMed ID: 30695468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management.
    McPherson S; Hardy T; Henderson E; Burt AD; Day CP; Anstee QM
    J Hepatol; 2015 May; 62(5):1148-55. PubMed ID: 25477264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies.
    Reddy YK; Marella HK; Jiang Y; Ganguli S; Snell P; Podila PSB; Maliakkal B; Satapathy SK
    J Clin Exp Hepatol; 2020; 10(3):245-254. PubMed ID: 32405181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease.
    Lai LL; Chan WK; Sthaneshwar P; Nik Mustapha NR; Goh KL; Mahadeva S
    PLoS One; 2017; 12(4):e0174982. PubMed ID: 28369100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage.
    Yoneda M; Mawatari H; Fujita K; Yonemitsu K; Kato S; Takahashi H; Kirikoshi H; Inamori M; Nozaki Y; Abe Y; Kubota K; Saito S; Iwasaki T; Terauchi Y; Togo S; Maeyama S; Nakajima A
    J Gastroenterol; 2007 May; 42(5):375-81. PubMed ID: 17530362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease.
    Arora A; Sharma P
    J Clin Exp Hepatol; 2012 Jun; 2(2):145-55. PubMed ID: 25755423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis.
    Shimada M; Kawahara H; Ozaki K; Fukura M; Yano H; Tsuchishima M; Tsutsumi M; Takase S
    Am J Gastroenterol; 2007 Sep; 102(9):1931-8. PubMed ID: 17511754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease.
    Zachou K; Azariadis K; Lytvyak E; Snijders RJALM; Takahashi A; Gatselis NK; Robles M; Andrade RJ; Schramm C; Lohse AW; Tanaka A; Drenth JPH; Montano-Loza AJ; Dalekos GN;
    JHEP Rep; 2023 Aug; 5(8):100778. PubMed ID: 37456672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease.
    Sumida Y; Yoneda M; Hyogo H; Yamaguchi K; Ono M; Fujii H; Eguchi Y; Suzuki Y; Imai S; Kanemasa K; Fujita K; Chayama K; Yasui K; Saibara T; Kawada N; Fujimoto K; Kohgo Y; Okanoue T;
    J Gastroenterol; 2011 Feb; 46(2):257-68. PubMed ID: 20842510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Liu CH; Ampuero J; Gil-Gómez A; Montero-Vallejo R; Rojas Á; Muñoz-Hernández R; Gallego-Durán R; Romero-Gómez M
    J Hepatol; 2018 Dec; 69(6):1335-1348. PubMed ID: 30142428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Small Intestinal Bacterial Overgrowth Syndrome in Patients with Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis: A Cross-Sectional Study.
    Gkolfakis P; Tziatzios G; Leite G; Papanikolaou IS; Xirouchakis E; Panayiotides IG; Karageorgos A; Millan MJ; Mathur R; Weitsman S; Dimitriadis GD; Giamarellos-Bourboulis EJ; Pimentel M; Triantafyllou K
    Microorganisms; 2023 Mar; 11(3):. PubMed ID: 36985296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory Protein Signatures as Predictive Disease-Specific Markers for Non-Alcoholic Steatohepatitis (NASH).
    Mounika N; Mungase SB; Verma S; Kaur S; Deka UJ; Ghosh TS; Adela R
    Inflammation; 2024 Apr; ():. PubMed ID: 38676759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study.
    Imajo K; Hyogo H; Yoneda M; Honda Y; Kessoku T; Tomeno W; Ogawa Y; Taguri M; Mawatari H; Nozaki Y; Fujita K; Kirikoshi H; Saito S; Sumida Y; Ono M; Wada K; Nakajima A; Eguchi Y
    PLoS One; 2014; 9(12):e115403. PubMed ID: 25541989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.